A routine medication adjustment turned into a serious medical scare after a 55-year-old woman developed an unexpected and painful skin reaction, highlighting how even commonly prescribed treatments can occasionally lead to rare complications.
The woman had long managed hypertension and chronic obstructive pulmonary disease (COPD) without major issues. Her conditions were stable on enalapril for blood pressure and a formoterol-based inhaler for respiratory support. There were no recent illnesses, lifestyle changes, or warning signs that anything was wrong.
That changed soon after her inhaler was switched to a combination therapy containing indacaterol and glycopyrronium, a widely used long-acting bronchodilator for COPD. Not long after starting the new medication, she began experiencing sudden, intensely painful red patches on her face and neck, accompanied by low-grade fever and overall discomfort.
The skin lesions were sharply defined, inflamed, and extremely tender. Concerned by the rapid progression, she sought medical care. Importantly, she reported no new skincare products, foods, environmental exposures, infections, or travel, and had no history of autoimmune or chronic skin conditions.
Doctors quickly suspected a drug-related reaction, given the timing of symptoms. The new inhaler was immediately discontinued, and she was started on oral corticosteroids to control inflammation. Blood tests showed elevated white blood cells with increased neutrophils, signaling an acute inflammatory response. However, extensive testing ruled out infection, autoimmune disease, and systemic illness.
Continue reading on next page…